Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katelyn A Pastick

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Human Immunology|June 14, 2026
Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIVCaleb P Skipper, Biyue Dai, Bruno Borges, et al.
Open Forum Infectious Diseases|September 21, 2023
Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIVJayne Ellis, Ananta S Bangdiwala, Caleb P Skipper, et al.
Open Forum Infectious Diseases|February 8, 2021
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global PandemicMatthew F Pullen, Katelyn A Pastick, Darlisha A Williams, et al.
The Lancet. Infectious Diseases|July 27, 2019
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trialJoshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Human Immunology|June 14, 2026
Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIVCaleb P Skipper, Biyue Dai, Bruno Borges, et al.
Open Forum Infectious Diseases|September 21, 2023
Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIVJayne Ellis, Ananta S Bangdiwala, Caleb P Skipper, et al.
Open Forum Infectious Diseases|February 8, 2021
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global PandemicMatthew F Pullen, Katelyn A Pastick, Darlisha A Williams, et al.
The Lancet. Infectious Diseases|July 27, 2019
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trialJoshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Pageof 3